Jaypirca (pirtobrutinib) — Highmark
quantity limit exception
Initial criteria
- additional quantities up to 3 tablets per day (100 mg) OR up to 3 tablets per day (50 mg) may be approved when the member is taking a moderate CYP3A4 inducer
Approval duration
12 months